Showing results (121-130 of 188) with videos related to

Sort By:
Pageof 19
Fertility and Sterility|January 1, 1989
Effects of the severity of tubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embryo transferS Oehninger, R Scott, S J Muasher, et al.
Gynecologic Oncology|March 1, 1987
Simultaneous radiation and chemotherapy for advanced carcinoma of the cervixD E Brenner, A W Gillette, H W Jones, et al.
The Journal of Reproductive Medicine|May 1, 1996
Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization programT L Toth, J T Awwad, L L Veeck, et al.
Journal of in Vitro Fertilization and Embryo Transfer : IVF|October 1, 1988
In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosisS Oehninger, A A Acosta, D Kreiner, et al.
Journal of Assisted Reproduction and Genetics|November 21, 1998
Plasma substance-P and substance-K and gonadal steroids in relation to the gonadotropin surge in normal human reproductive cyclesD L Mohyi, B Kerdelhué, V Lenoir, et al.
Annals of the New York Academy of Sciences|January 11, 1991
Endometrial receptivities after leuprolide suppression and gonadotropin stimulation: histology, steroid receptor concentrations, and implantation ratesJ P Toner, D K Hassiakos, S J Muasher, et al.
Obstetrics and Gynecology|February 1, 1982
A genetic male patient with 17 alpha-hydroxylase deficiencyH W Jones, P A Lee, J A Rock, et al.
Fertility and Sterility|August 6, 2000
Histochemical localization of endometrial insulin-like growth factor binding protein-1 and -3 during the luteal phase in controlled ovarian hyperstimulation cycles: a controlled studyS E Brown, E Mandelin, S Oehninger, et al.
Fertility and Sterility|July 19, 2000
Endometrial glycodelin-A expression in the luteal phase of stimulated ovarian cyclesS E Brown, E Mandelin, S Oehninger, et al.
American Journal of Clinical Oncology|October 1, 1990
The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP)J D Hainsworth, H W Jones, L S Burnett, et al.
Pageof 19